TuHURA BIOSCIENCES, INC./NV Other Selling, General and Administrative Expense
TuHURA BIOSCIENCES, INC./NV (HURA) reported Other Selling, General and Administrative Expense of $0 for the 3-month period ending 2012-12-31, per its 10-Q filed 2013-01-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2013-01-18
- TuHURA BIOSCIENCES, INC./NV other selling, general and administrative expense for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV other selling, general and administrative expense for the quarter ending 2012-09-30 was $375.00, a 46.12% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV other selling, general and administrative expense for the quarter ending 2012-06-30 was $982.00, a 85.08% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV other selling, general and administrative expense for the quarter ending 2012-03-31 was $1.44K, a 56.09% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV other selling, general and administrative expense for fiscal 2012 was $7.31K, a 67.43% decline from fiscal 2011.
- TuHURA BIOSCIENCES, INC./NV other selling, general and administrative expense for fiscal 2011 was $22.43K.
| Period end | Other Selling, General and Administrative Expense 3 month | Other Selling, General and Administrative Expense 6 month | Other Selling, General and Administrative Expense 9 month | Other Selling, General and Administrative Expense 12 month | Other Selling, General and Administrative Expense 27 month | Other Selling, General and Administrative Expense 30 month | Other Selling, General and Administrative Expense 33 month | Other Selling, General and Administrative Expense 36 month | Other Selling, General and Administrative Expense 39 month | Other Selling, General and Administrative Expense 42 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-12-31 | $0.00 10-Q · filed 2013-01-18 | $375.00 10-Q · filed 2013-01-18 | $1.36K derived: sum of 3 quarters · filed 2013-01-18 | $2.80K derived: sum of 4 quarters · filed 2013-01-18 | $31.27K 10-Q · filed 2013-01-18 | |||||
| 2012-09-30 | $375.00 10-Q/A · filed 2012-12-20 | $1.36K derived: sum of 2 quarters · filed 2012-12-20 | $2.80K derived: sum of 3 quarters · filed 2012-12-20 | $6.99K derived: sum of 4 quarters · filed 2013-01-18 | $31.27K 10-Q/A · filed 2012-12-20 | |||||
| 2012-06-30 | $982.00 10-K/A · filed 2012-12-20 | $2.42K derived: sum of 2 quarters · filed 2012-12-20 | $6.61K derived: sum of 3 quarters · filed 2013-01-18 | $7.31K 10-K/A · filed 2012-12-20 | $30.89K 10-K/A · filed 2012-12-20 | |||||
| 2012-03-31 | $1.44K 10-Q/A · filed 2012-06-05 | $5.63K derived: sum of 2 quarters · filed 2013-01-18 | $6.33K 10-Q/A · filed 2012-06-05 | $12.91K derived: sum of 4 quarters · filed 2013-01-18 | $29.91K 10-Q/A · filed 2012-06-05 | |||||
| 2011-12-31 | $4.19K 10-Q · filed 2013-01-18 | $4.89K 10-Q · filed 2013-01-18 | $11.47K derived: sum of 3 quarters · filed 2013-01-18 | $14.74K derived: sum of 4 quarters · filed 2013-01-18 | $28.47K 10-Q · filed 2012-02-07 | |||||
| 2011-09-30 | $696.00 10-Q/A · filed 2012-12-20 | $7.28K derived: sum of 2 quarters · filed 2012-12-20 | $10.55K derived: sum of 3 quarters · filed 2012-12-20 | $11.63K derived: sum of 4 quarters · filed 2012-12-20 | $24.28K 10-Q · filed 2011-11-10 | |||||
| 2011-06-30 | $6.58K 10-K/A · filed 2012-12-20 | $9.86K derived: sum of 2 quarters · filed 2012-12-20 | $10.93K derived: sum of 3 quarters · filed 2012-12-20 | $22.43K 10-K/A · filed 2012-12-20 | ||||||
| 2011-03-31 | $3.28K 10-Q/A · filed 2012-06-05 | $4.35K derived: sum of 2 quarters · filed 2012-06-05 | $15.85K 10-Q/A · filed 2012-06-05 | |||||||
| 2010-12-31 | $1.07K 10-Q · filed 2012-02-07 | $2.58K 10-Q · filed 2012-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |